Noguchi T, Mattei M G, Oberlè I, Planche J, Imbert J, Pelassy C, Birg F, Birnbaum D
EMBO J. 1987 May;6(5):1301-7. doi: 10.1002/j.1460-2075.1987.tb02368.x.
A transforming sequence was identified using co-transfection of DNA from the human mammary carcinoma cell line MCF-7 and of a G418 resistance gene into NIH 3T3 cells, followed by tumor formation in athymic mice. This sequence, named mcf.2, was molecularly cloned. A transforming activity resides in a cosmid clone of 42 kb. mcf.2 did not cross-hybridize with the known oncogenes tested. In situ hybridization localized it on the X chromosome, probably at q27. This localization was confirmed by hybridization to a panel of human--rodent cell line DNAs.
通过将来自人乳腺癌细胞系MCF-7的DNA与G418抗性基因共转染到NIH 3T3细胞中,随后在无胸腺小鼠中形成肿瘤,鉴定出了一个转化序列。这个名为mcf.2的序列被进行了分子克隆。转化活性存在于一个42 kb的黏粒克隆中。mcf.2与所检测的已知癌基因没有交叉杂交。原位杂交将其定位在X染色体上,可能位于q27。通过与一组人-啮齿动物细胞系DNA杂交证实了这种定位。